As CMRI works towards the future, we continue to rely heavily on the enduring relationships developed over the last 65 years, and to seek out new scientific, clinical and industry partners who share our goals.
At just two weeks old, Alessia was diagnosed with Spinal Muscular Atrophy. Thanks to ground-breaking gene therapy, Alessia became the first child in Australia to receive life-saving treatment, giving her a future her parents thought they might never see.